Higher-dose pneumococcal vaccines improve immune response in ANCA-associated vasculitis patients receiving rituximab
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients ...
Nov 8, 2022
0
2